Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Inspire Medical Systems, Inc. (INSP : NYSE)
 
 • Company Description   
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.

Number of Employees: 1,246

 
 • Price / Volume Information   
Yesterday's Closing Price: $81.79 Daily Weekly Monthly
20 Day Moving Average: 1,190,472 shares
Shares Outstanding: 29.06 (millions)
Market Capitalization: $2,376.53 (millions)
Beta: 1.14
52 Week High: $216.01
52 Week Low: $70.77
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 8.81% 5.96%
12 Week -6.81% -10.68%
Year To Date -55.88% -61.44%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
5500 WAYZATA BLVD SUITE 1600
-
GOLDEN VALLEY,MN 55416
USA		 ph: 844-672-4357
fax: -		 ezgiyagci@inspiresleep.com http://www.inspiresleep.com
 
 • General Corporate Information   
Officers
Timothy P. Herbert - President and Chief Executive Officer
Richard Buchholz - Chief Financial Officer
Shelley G. Broader - Director
Gary L. Ellis - Director
Cynthia B. Burks - Director

Peer Information
Inspire Medical Systems, Inc. (HLIS)
Inspire Medical Systems, Inc. (AZTA)
Inspire Medical Systems, Inc. (APYI)
Inspire Medical Systems, Inc. (RNVA)
Inspire Medical Systems, Inc. (HMSY)
Inspire Medical Systems, Inc. (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 457730109
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 02/09/26
Share - Related Items
Shares Outstanding: 29.06
Most Recent Split Date: (:1)
Beta: 1.14
Market Capitalization: $2,376.53 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.70 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $1.60 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 5.76% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/09/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 51.06
Trailing 12 Months: 39.32
PEG Ratio: 8.86
Price Ratios
Price/Book: 3.57
Price/Cash Flow: 47.87
Price / Sales: 2.69
EPS Growth
vs. Year Ago Period: -36.67%
vs. Previous Quarter: -15.56%
Sales Growth
vs. Year Ago Period: 10.49%
vs. Previous Quarter: 3.42%
ROE
09/30/25 - 9.41
06/30/25 - 10.38
03/31/25 - 10.00
ROA
09/30/25 - 7.97
06/30/25 - 8.93
03/31/25 - 8.68
Current Ratio
09/30/25 - 5.29
06/30/25 - 6.14
03/31/25 - 9.01
Quick Ratio
09/30/25 - 4.01
06/30/25 - 4.84
03/31/25 - 7.44
Operating Margin
09/30/25 - 7.11
06/30/25 - 8.13
03/31/25 - 7.92
Net Margin
09/30/25 - 5.05
06/30/25 - 6.17
03/31/25 - 7.92
Pre-Tax Margin
09/30/25 - 5.89
06/30/25 - 6.83
03/31/25 - 8.57
Book Value
09/30/25 - 22.94
06/30/25 - 22.92
03/31/25 - 21.36
Inventory Turnover
09/30/25 - 1.20
06/30/25 - 1.45
03/31/25 - 1.68
Debt-to-Equity
09/30/25 - 0.00
06/30/25 - 0.00
03/31/25 - 0.00
Debt-to-Capital
09/30/25 - 0.00
06/30/25 - 0.00
03/31/25 - 0.00
 

Powered by Zacks Investment Research ©